Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Short-Term Debt repayments (2025)

Historic Short-Term Debt repayments for Arrowhead Pharmaceuticals (ARWR) over the last 1 years, with Q2 2025 value amounting to $50.0 million.